Identification of POLQ as a chromosomal instability-associated biomarker for hepatocellular carcinoma

Identification of POLQ as a chromosomal instability-associated biomarker for hepatocellular carcinoma

Saved in:

Bibliographic Details
Main Authors:	Ying Cai, Na Wang, Qiang Liu, Yidi Wang, Dina Liu, Jing Liu, Hengyu Zhou
Format:	Article
Language:	English
Published:	KeAi Communications Co., Ltd. 2025-11-01
Series:	Genes and Diseases
Online Access:	http://www.sciencedirect.com/science/article/pii/S235230422500042X
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

POLQ mediated end-joining promotes DNA damage tolerance in neuroblastoma
by: Sahiti Chukkapalli, et al.
Published: (2025-08-01)

Preoperative plasma cell-free DNA chromosomal instability predicts microvascular invasion in hepatocellular carcinoma: a prospective study
by: Zheyue Shu, et al.
Published: (2025-05-01)

Discovery of novel diagnostic biomarkers of hepatocellular carcinoma associated with immune infiltration
by: Qiang Liu, et al.
Published: (2025-12-01)

Identification of CCDC58 as a potential predictive biomarker of immune cell infiltration in hepatocellular carcinoma
by: Zishen Liu, et al.
Published: (2025-04-01)

and as prognostic biomarkers for prognosis and palindromia of human hepatocellular carcinoma
by: Xin Zhang, et al.
Published: (2017-07-01)

Identification and validation of MMP1 as a biomarker associated with mitochondrial oxidative stress in liver hepatocellular carcinoma
by: Zhihui Wang, et al.
Published: (2025-07-01)

Identification of novel blood-based HCC-specific diagnostic biomarkers for human hepatocellular carcinoma
by: Li Yin, et al.
Published: (2019-12-01)

Serum-biomarker-based population screening model for hepatocellular carcinoma
by: Wenmin Liao, et al.
Published: (2025-03-01)

Evaluation of genetic instability of short tandem repeats in hepatocellular carcinoma
by: Yinghui Song, et al.
Published: (2025-07-01)

Identification of molecular subtypes based on pseudouridine modification in hepatocellular carcinoma
by: Weifeng Xu, et al.
Published: (2025-07-01)

Exosomal circPOLQ promotes macrophage M2 polarization via activating IL-10/STAT3 axis in a colorectal cancer model
by: Yang Liu, et al.
Published: (2024-05-01)

Identification of FDFT1 and PGRMC1 as New Biomarkers in Nonalcoholic Steatohepatitis (NASH)-Related Hepatocellular Carcinoma by Deep Learning
by: Liu Q, et al.
Published: (2025-04-01)

Bioinformatics-driven identification of key non-invasive prognostic biomarkers in hepatocellular carcinoma
by: Muhammad-Redha Abdullah-Zawawi, et al.
Published: (2025-04-01)

Identification of novel microRNAs: Biomarkers for pathogenesis of hepatocellular carcinoma in mice model
by: Shivani Priya, et al.
Published: (2025-03-01)

Distinct chromosome abnormality patterns for differential diagnosis of hepatocellular carcinoma and cholangiocarcinoma.
by: Wantakan Ngamsangiam, et al.
Published: (2025-01-01)

Predictive value of biomarkers for lenvatinib in hepatocellular carcinoma
by: Xiangyong Hao, et al.
Published: (2025-08-01)

FAN1-mediated translesion synthesis and POLQ/HELQ-mediated end joining generate interstrand crosslink-induced mutations
by: Jip Verschuren, et al.
Published: (2025-03-01)

Replication stress induces POLQ-mediated structural variant formation throughout common fragile sites after entry into mitosis
by: Thomas E. Wilson, et al.
Published: (2024-11-01)

The Progress and Prospects of Putative Biomarkers for Liver Cancer Stem Cells in Hepatocellular Carcinoma
by: Yan Xiang, et al.
Published: (2016-01-01)

Identification of FABP5 as an immunometabolic marker in human hepatocellular carcinoma
by: Yan Lu, et al.
Published: (2020-10-01)

APEX1 as a novel diagnostic and prognostic biomarker for hepatocellular carcinoma
by: Nourhan Assem, et al.
Published: (2025-05-01)

Chromosomal instability in human trophoblast stem cells and placentas
by: Danyang Wang, et al.
Published: (2025-04-01)

Identification of serum tsRNA-Thr-5-0015 and combined with AFP and PIVKA-II as novel biomarkers for hepatocellular carcinoma
by: Kangfeng Jin, et al.
Published: (2024-11-01)

The evolving landscape of biomarkers for systemic therapy in advanced hepatocellular carcinoma
by: Xinyu Guo, et al.
Published: (2025-04-01)

MRI Imaging Biomarkers for Prognostication of Hepatocellular Carcinoma
by: Ja Kyung Yoon, et al.
Published: (2025-05-01)

Identification and validation of the fibrosis-related molecular subtypes of hepatocellular carcinoma by bioinformatics
by: Ling-li Liu, et al.
Published: (2025-06-01)

PI16 attenuates response to sorafenib and represents a predictive biomarker in hepatocellular carcinoma
by: Pusen Wang, et al.
Published: (2020-10-01)

ARIH2 serves as a potential prognostic biomarker for hepatocellular carcinoma associated with immune infiltration and ferroptosis
by: Qiang Shu, et al.
Published: (2025-04-01)

Identification of HES4 as a novel prognostic marker and therapeutic target in hepatocellular carcinoma
by: Yungang Liu, et al.
Published: (2025-02-01)

Identification of prognostic biomarkers related to epithelial-mesenchymal transition and anoikis in hepatocellular carcinoma using transcriptomics and single-cell sequencing
by: Maobing Wang, et al.
Published: (2025-06-01)

Chromosomal instability in patients with Fanconi anemia from Serbia
by: Ćirković Sanja, et al.
Published: (2014-01-01)

DDX21 Is a Potential Biomarker for Predicting Recurrence and Prognosis in Hepatocellular Carcinoma
by: Chengjie Ji, et al.
Published: (2025-01-01)

In silico identification of novel gene biomarkers in Liver Hepatocellular Carcinoma (LIHC) with specialized epigenetics informatics tools
by: Mohamad Zafran AMINUDDIN, et al.
Published: (2025-06-01)

DCP as a biomarker for TACE efficacy in hepatocellular carcinoma
by: Hui Xie, et al.
Published: (2025-07-01)

The role of bile acid metabolism-related genes in prognosis assessment of hepatocellular carcinoma and identification of NPC1 as a biomarker
by: Maosen Xu, et al.
Published: (2025-05-01)

CHPF2 as a novel biomarker and ponicidin as a potential therapeutic agent in hepatocellular carcinoma
by: Zuhui Liang, et al.
Published: (2025-05-01)

Identification of key molecular targets for stachyose in hepatocellular carcinoma: focus on STAT3 and FN1
by: Haihua Chen, et al.
Published: (2025-07-01)

RACGAP1 and MKI67 are potential prognostic biomarker in hepatocellular carcinoma caused by HBV/HCV via lactylation
by: Muhammad Muddasar Saeed, et al.
Published: (2025-05-01)

micronuclAI enables automated quantification of micronuclei for assessment of chromosomal instability
by: Miguel A. Ibarra-Arellano, et al.
Published: (2025-03-01)

Asparagine synthetase modulates glutaminase inhibitor sensitivity through metabolic reprogramming and serves as a prognostic biomarker in hepatocellular carcinoma
by: Benjian Gao, et al.
Published: (2025-10-01)